Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-17-002729)

Filing Details

Accession Number:: 0001562180-17-002729
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-08-17 16:06:11
Reporting Period:: 2017-08-15

Filing Date:: 2017-08-17
Accepted Time:: 2017-08-17 16:06:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1517022	Akebia Therapeutics Inc.	AKBA	Pharmaceutical Preparations (2834)	208756903

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1669737	Michel Dahan	C/O Akebia Therapeutics, Inc. 245 First Street Cambridge MA 02142	Svp, Chief Business Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-08-15	5,000	$15.00	102,224	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 15, 2017.